M. Distel

785 total citations
14 papers, 584 citations indexed

About

M. Distel is a scholar working on Pharmacology, Rheumatology and Infectious Diseases. According to data from OpenAlex, M. Distel has authored 14 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 6 papers in Rheumatology and 3 papers in Infectious Diseases. Recurrent topics in M. Distel's work include Inflammatory mediators and NSAID effects (10 papers), Drug-Induced Adverse Reactions (4 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). M. Distel is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Drug-Induced Adverse Reactions (4 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). M. Distel collaborates with scholars based in Germany, United Kingdom and Egypt. M. Distel's co-authors include Erich Bluhmki, Claudia Mueller, James F. Fries, J. Hosie, B. Lindén, Birger Lund, Jean‐Yves Reginster, Peter J.R. Bevis, H. S. Goei Thè and David W. Haas and has published in prestigious journals such as The Journal of Infectious Diseases, AIDS and Osteoarthritis and Cartilage.

In The Last Decade

M. Distel

13 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Distel Germany	10	420	112	98	88	72	14	584
Amanda Freeman United States	11	188 0.4×	80 0.7×	45 0.5×	17 0.2×	9 0.1×	13	748
Moo Nahm Yum United States	13	228 0.5×	71 0.6×	47 0.5×	16 0.2×	22 0.3×	19	732
Jutta Miller United States	12	120 0.3×	49 0.4×	31 0.3×	15 0.2×	44 0.6×	20	483
Jon Ruckle United States	12	66 0.2×	36 0.3×	50 0.5×	41 0.5×	14 0.2×	22	672
M Zschiesche Germany	12	90 0.2×	190 1.7×	21 0.2×	23 0.3×	44 0.6×	44	764
Masataka Katashima Japan	13	72 0.2×	104 0.9×	36 0.4×	19 0.2×	19 0.3×	46	513
P. Rolan United Kingdom	10	57 0.1×	82 0.7×	15 0.2×	26 0.3×	21 0.3×	14	619
Pär Westlund Sweden	13	142 0.3×	32 0.3×	15 0.2×	26 0.3×	31 0.4×	26	679
Jean–Paul Fillastre France	12	149 0.4×	33 0.3×	12 0.1×	13 0.1×	56 0.8×	28	553
J H Lin United States	13	107 0.3×	192 1.7×	19 0.2×	17 0.2×	14 0.2×	17	769

Countries citing papers authored by M. Distel

Since Specialization

Citations

This map shows the geographic impact of M. Distel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Distel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Distel more than expected).

Fields of papers citing papers by M. Distel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Distel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Distel. The network helps show where M. Distel may publish in the future.

Co-authorship network of co-authors of M. Distel

This figure shows the co-authorship network connecting the top 25 collaborators of M. Distel. A scholar is included among the top collaborators of M. Distel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Distel. M. Distel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Yuan, Jing, Sheng Guo, David B. Hall, et al.. (2011). Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent. AIDS. 25(10). 1271–1280. 110 indexed citations

Seclén, Eduardo, Vincent Soriano, Luz Martı́n-Carbonero, et al.. (2011). Impact of Baseline HIV-1 Tropism on Viral Response and CD4 Cell Count Gains in HIV-Infected Patients Receiving First-line Antiretroviral Therapy. The Journal of Infectious Diseases. 204(1). 139–144. 26 indexed citations

Seclén, Eduardo, María del Mar González, Luz Martı́n-Carbonero, et al.. (2010). Impact of baseline HIV‐1 tropism on viral response and CD4 gains in antiretroviral‐naïve patients. Journal of the International AIDS Society. 13(S4). 5 indexed citations

Distel, M.. (1998). Meloxicam Clinical Data on a Preferential Cyclooxygenase-2 Inhibitor. JCR Journal of Clinical Rheumatology. 4(Supplement). 32–39. 4 indexed citations

Lemmel, E.‐M., W. Bolten, Rubén Burgos‐Vargas, et al.. (1997). Efficacy and safety of meloxicam in patients with rheumatoid arthritis.. PubMed. 24(2). 282–90. 35 indexed citations

Thè, H. S. Goei, Birger Lund, M. Distel, & Erich Bluhmki. (1997). A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage. 5(4). 283–288. 41 indexed citations

Hosie, J., M. Distel, & Erich Bluhmki. (1997). Efficacy and Tolerability of Meloxicam versus Piroxicam in Patients with Osteoarthritis of the Hip or Knee. Clinical Drug Investigation. 13(4). 175–184. 22 indexed citations

Wojtulewski, J. A., M Schattenkirchner, Xavier Le Loët, et al.. (1996). A Six-Month Double-Blind Trial to Compare the Efficacy and Safety of Meloxicam 7.5 mg Daily and Naproxen 750 mg Daily in Patients with Rheumatoid Arthritis. Lara D. Veeken. 35(suppl 1). 22–28. 56 indexed citations

Prouse, P., Peter J.R. Bevis, Erich Bluhmki, & M. Distel. (1996). Evaluation of the safety, tolerability, and efficacy of meloxicam tablets in patients with osteoarthritis. Clinical Therapeutics. 18(3). 429–439. 9 indexed citations

10.

Reginster, Jean‐Yves, M. Distel, & Erich Bluhmki. (1996). A Double-Blind, Three-Week Study to Compare the Efficacy and Safety of Meloxicam 7.5 mg and Meloxicam 15 mg in Patients with Rheumatoid Arthritis. Lara D. Veeken. 35(suppl 1). 17–21. 29 indexed citations

11.

Lindén, B., M. Distel, & Erich Bluhmki. (1996). A Double-Blind Study to Compare the Efficacy and Safety of Meloxicam 15 mg with Piroxicam 20 mg in Patients with Osteoarthritis of the HIP. Lara D. Veeken. 35(suppl 1). 35–38. 48 indexed citations

12.

Hosie, J., M. Distel, & Erich Bluhmki. (1996). Meloxicam in Osteoarthritis: A 6-Month, Double-Blind Comparison with Diclofenac Sodium. Lara D. Veeken. 35(suppl 1). 39–43. 66 indexed citations

13.

Distel, M., Claudia Mueller, Erich Bluhmki, & James F. Fries. (1996). Safety of Meloxicam: A Global Analysis of Clinical Trials. Lara D. Veeken. 35(suppl 1). 68–77. 132 indexed citations

14.

Hosie, J., M. Distel, & Erich Bluhmki. (1996). MELOXICAM IN OSTEOARTHRITIS. A SIX-MONTH DOUBLE COMPARISON WITH DICLOFENAC. 35. 39–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact